2025 Flu Season 2025

2025 Flu Season 2025. Infographic Influenza in Europe, 20192023 Make recommendations on the composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season; and Review the antigenic and genetic characteristics of recent A(H5/H9) and other subtype or variant zoonotic influenza viruses) that the WHO Collaborating Centres of the GISRS received and the need to develop new candidate vaccine viruses for pandemic preparedness. reporting of the weekly influenza vaccine uptake for the 2024 to 2025 season has concluded (up to the end of week 4 ending 26 January 2025, vaccine uptake was 39.7% for those under 65 years in a.

During the 2025 to 2026 flu immunisation programme monthly data. Providers should ensure they complete these data returns through ImmForm during the appropriate time windows throughout the season

About This Year's Flu Maricopa County, AZ

Ordering copies of flu resources 12 Annual flu programme resources 2024 to 2025 Paper copies of most resources are available to order at: www.healthpublications.gov.uk The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere The key changes to the flu vaccination programme for the 2024 to 2025 flu season are: •change to recommendations as to when the flu vaccine should be given •change to the live attenuated influenza vaccine (LAIV) from a quadrivalent to a trivalent vaccine •the recombinant quadrivalent influenza vaccine (QIVr) will not be available for the

Twothirds of states reporting 'very high' or 'high' levels of flulike activity CDC Good. Today, the FDA made recommendations to vaccine manufacturers for the virus strains to be used in the trivalent (three strain) flu vaccines for the 2025-2026 U.S The key changes to the flu vaccination programme for the 2024 to 2025 flu season are: •change to recommendations as to when the flu vaccine should be given •change to the live attenuated influenza vaccine (LAIV) from a quadrivalent to a trivalent vaccine •the recombinant quadrivalent influenza vaccine (QIVr) will not be available for the

Influenza Activity in the United States during the 20232024 Season and Composition of the 2024. Make recommendations on the composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season; and Review the antigenic and genetic characteristics of recent A(H5/H9) and other subtype or variant zoonotic influenza viruses) that the WHO Collaborating Centres of the GISRS received and the need to develop new candidate vaccine viruses for pandemic preparedness. Providers should ensure they complete these data returns through ImmForm during the appropriate time windows throughout the season